Target intelligence / Profile preview

T-cell surface glycoprotein CD3 epsilon chain (CD3E)

Target
CD3E
Molecular classification
Receptor, Cell surface glycoprotein, Immunoreceptor, CD (cluster of differentiation) molecule
01

Overview

The **T-cell surface glycoprotein CD3 epsilon chain (CD3E)** is one of four distinct polypeptide chains (epsilon, gamma, delta, and zeta) forming the **CD3 complex**, which is essential for the surface expression and signaling function of the T cell receptor (TCR) in T lymphocytes[1][2][5][6]. CD3E contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic tail, which relays signal transduction from the antigen-engaged TCR to intracellular signaling pathways, thus playing a pivotal role in T cell activation, development, and immune responses[1][6]. Loss or mutation of the CD3E gene causes severe immunodeficiency, and CD3E is a well-established therapeutic and diagnostic target, notably for monoclonal antibody therapies that modulate T cell activity in contexts such as transplantation, autoimmune disease, and hematological cancers[5][6].

Other names
CD3 epsilonCD3ET lymphocyte surface antigen CD3 epsilon chainT cell surface glycoprotein CD3 epsilon chainCD3-epsilon chainCluster of differentiation 3 epsilon
02

Mechanism of action

Monoclonal antibodies binding to CD3 epsilon induce T cell receptor modulation and T cell apoptosis or anergy - Block or modulate T-cell activation - Deplete T cells or modulate T cell function via Fc-mediated cytotoxic effects

03

Biological functions

Signal transductionAntigen recognitionAdaptive immune responseT-cell developmentT-cell activationIntracellular signaling
04

Disease associations

Immunodeficiency (e.g. severe combined immunodeficiency)Autoimmunity (e.g. susceptibility to type I diabetes)Cancer (therapeutic target in leukemia/lymphoma)InflammationOther immune-related diseases
05

Safety considerations

Cytokine release syndrome (especially with anti-CD3 antibodies)Immunosuppression leading to increased risk of infectionRisk of autoimmune reaction due to T-cell modulation
06

Interacting drugs

Muromonab-CD3 (OKT3)

2 more in the full profile.

07

Biomarkers

CD3 (including CD3 epsilon) is routinely used as a biomarker for T-cell identification in flow cytometry and tissue stainingUsed to monitor T-cell presence and status in hematological malignancies and immune monitoring

Beyond the preview

Go deeper on T-cell surface glycoprotein CD3 epsilon chain (CD3E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell surface glycoprotein CD3 epsilon chain (CD3E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call